Duloxetine in the management of diabetic peripheral neuropathic pain

References

• Centers for Disease Control and PreventionNational Diabetes Fact Sheet2007 Available at: https://apps.nccd.cdc.gov/DDTSTRS/FactSheet.aspx. Accessed May 20, 2011.
   Google Scholar
• Centers for Disease Control and PreventionDiabetes: disabling, deadly, and on the rise2005 Available at: http://www.cdc.gov/diabetes. Accessed May 20, 2011.
   Google Scholar
• National Institute of Diabetes and Digestive and Kidney DiseasesDiabetic Neuropathies: The Nerve Damage of Diabetes. NIH Publication No. 02-3185.52002 Available at: http://permanent.access.gpo.gov/lps19677/www.niddk.nih.gov/health/diabetes/pubs/neuro/neuro.htm. Accessed May 20, 2011.
   Google Scholar
• DyckPJKratzKMKarnesJLThe prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy StudyNeurology1993438178248469345
   PubMed Web of Science ®Google Scholar
• TreedeRDJensenTSCampbellJNNeuropathic pain: redefinition and a grading system for clinical and research diagnostic purposesNeurology2008701630163518003941
   PubMed Web of Science ®Google Scholar
• DaviesMBrophySWilliamsRTaylorAThe prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetesDiabetes Care2006291518152216801572
   PubMed Web of Science ®Google Scholar
• GalerBSGianansAJensenMPPainful diabetic polyneuropathy: epidemiology, pain description, and quality of lifeDiabetes Res Clin Pract20004712312810670912
   PubMed Web of Science ®Google Scholar
• JensenPGLarsonJRManagement of painful diabetic neuropathyDrugs Aging20011873774911735621
   PubMed Web of Science ®Google Scholar
• VevesAManesCMurrayHJYoungMJBoultonAJPainful neuropathy and foot ulceration in diabetic patientsDiabetes Care199316118711898375249
   PubMed Web of Science ®Google Scholar
• GordoisAScuffhamPShearerAOglesbyATobianJAThe health care costs of diabetic peripheral neuropathy in the USDiabetes Care2003261790179512766111
   PubMed Web of Science ®Google Scholar
• WuNChenSBoulangerLDuloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic painJ Med Economics200912192202
   PubMedGoogle Scholar
• BouleNGHaddadEKennyGPWellsGASigalRJEffects of exercise on glycemic control and body mass in type 2 diabetes mellitus. A meta-analysis of controlled clinical trialsJAMA20012861218122711559268
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationStandards of Medical Care in Diabets-2010Diabetes Care201033Suppl 1S11S6120042772
   PubMed Web of Science ®Google Scholar
• QuattriniCTesfayeSUnderstanding the impact of painful diabetic neuropathyDiabetes Metab Res Rev200319S2S812577252
   PubMed Web of Science ®Google Scholar
• SpiegelKLeproultRVan CauterEImpact of sleep dept on metabolic and endocrine functionLancet19993541435143910543671
   PubMed Web of Science ®Google Scholar
• Pfizer LYRICA DPN Physician ATU Study2262007Pfizer IncNew York
   Google Scholar
• BergerADukesEMOsterGClinical characteristics and economic costs of patients with painful neuropathic disordersJ Pain2004514314915106126
   PubMed Web of Science ®Google Scholar
• SorensenLMolyneauxLYueDInsensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycemic controlDiabetes Res Clin Pract200257455112007729
   PubMed Web of Science ®Google Scholar
• TesfayeSSelvarajahDThe Eurodiab study: what has this taught us about diabetic peripheral neuropathy?Current Diabetes Reports2009943243419954687
   PubMed Web of Science ®Google Scholar
• GemignaniFAcute painful diabetic neuropathy induced by strict glycemic control (“insulin neuritis”): the old enigma is still unsolvedBiomed Pharmacother20096324925019250797
   PubMed Web of Science ®Google Scholar
• GibbonsCHFreemanRTreatment-induced diabetic neuropathy: a reversible painful autonomic neuropathyAnn Neurol20106753454120437589
   PubMed Web of Science ®Google Scholar
• [No authors listed].The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research GroupAnn Intern Med19951225615687887548
   PubMed Web of Science ®Google Scholar
• AmthorKFDahl-JorgensenKBergTJThe effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo StudyDiabetologia1994375795847926342
   PubMed Web of Science ®Google Scholar
• OyiboSOPrasadYDJacksonNJThe relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot studyDiabet Med20021987087312358878
   PubMed Web of Science ®Google Scholar
• BoultonAJDruryJClarkeBWardJDContinuous subcutaneous insulin infusion in the management of painful diabetic neuropathyDiabetes Care198253863907151654
   PubMed Web of Science ®Google Scholar
• ArcherAGWatkinsPJThomasPKThe natural history of acute painful neuropathy in diabetes mellitusJ Neurol Neurosurg Psychiatry1983464914996875582
   PubMed Web of Science ®Google Scholar
• Cymbalta [package insert]Indianapolis, INEli Lilly and Company52011
   Google Scholar
• FieldsHLBasbaumAIHeinricherMMCentral nervous system mechanisms of pain modulationMcMahonSBKoltzenbergMWall and Melzack’s Textbook of Pain5th edLondon, UKElsevier, Churchill, Livingston2006125142
   Google Scholar
• Lyrica [package insert]New YorkPfizer Inc20115
   Google Scholar
• ArgoffCEBackonjaMMBelgradeMJConsensus guidelines: treatment planning and optionsMayo Clin Proc200681Suppl 4S12S2516608049
   PubMed Web of Science ®Google Scholar
• BrilVEnglandJFranklinGMEvidence-based Guideline: treatment of Painful Diabetic Neuropathy, Report of the American Academy of Neurology the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Published concurrently in: Neurology. 2011;76:1758–65; Phys Med Rehab. 2011;3:345–352. e21Muscle Nerve20114391091721484835
   PubMed Web of Science ®Google Scholar
• SimpsonDAGabapentin and venlafaxine for the treatment of painful diabetic neuropathyJ Clin Neuromuscul Dis20013536219078655
   PubMedGoogle Scholar
• RaskinJPritchettYLWangFA double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic painPain Medicine2005634635616266355
   PubMed Web of Science ®Google Scholar
• GoldsteinDJLuYDetkeMDuloxetine vs placebo in patients with painful diabetic neuropathyPain200511610911815927394
   PubMed Web of Science ®Google Scholar
• WernickeJFPritchettYLD’SouzaDNA randomized controlled trial of duloxetine in diabetic peripheral neuropathic painNeurology2006671411142017060567
   PubMed Web of Science ®Google Scholar
• LunettaMLe MoliRGrassoGSangiorgioLA simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathyDiabetes Res Clin Practice199839165172
   PubMed Web of Science ®Google Scholar
• CleelandCSRyanKMPain assessment: global use of the Brief Pain InventoryAnn Acad Med Singapore1994231291388080219
   PubMedGoogle Scholar
• MelzackRThe short-form McGill Pain QuestionairePain1987301911973670870
   PubMed Web of Science ®Google Scholar
• AshkenaziAYoungWBDynamic mechanical (brush) allodynia in cluster headacheHeadache2004441010101215546264
   PubMed Web of Science ®Google Scholar
• HamiltonMA rating scale for depression 1960J Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• GuyWECDEI Assessment Manual for Psychopharmacology, Revised US Department of Health, Education, and Welfare Publication (ADM)Rockville, MDNational Institute of Mental Health197676338
   Google Scholar
• SamuelssonMLefflerAJohanssonBHanssonPOn the repeatability of brush-evoked allydynia using a novel semi-quantitative method in patients with peripheral neuropathic painPain2007130404617161534
   PubMed Web of Science ®Google Scholar
• WareJESnowKKKosinskiMGandekBSF-36 health survey manual and interpretation guideBoston, MAThe Health Institute, New England Medical Center1993
   Google Scholar
• The EuroQol GroupEuroQol-a new facility for the measurement of health-related quality of lifeHealth Policy19901619920810109801
   PubMed Web of Science ®Google Scholar
• BeckATSteerRABallRRanieriWComparison of Beck Depression Inventories −IA and −II in psychiatric outpatientsJ Pers Assess1996675885978991972
   PubMed Web of Science ®Google Scholar
• BeckATEpsteinNBrownGSteerRAAn inventory for measuring clinical anxiety: psychometric propertiesJ Consult Clin Psychol1988568938973204199
   PubMed Web of Science ®Google Scholar
• DworkinRHTurkDCWyrwichKWInterpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendationsJ Pain2008910512118055266
   PubMed Web of Science ®Google Scholar
• RaskinJSmithTRWongKDuloxetine versus routine care in the long-term management of diabetic peripheral neuropathic painJ Palliat Med20069294016430342
   PubMed Web of Science ®Google Scholar
• WernickeJRaskinJRosenADuloxetine in the long-term management of diabetic peripheral neuropathic pain: an open-label, 52-week extension of a randomized controlled clinical trialCurr Ther Res Clin Exp200667283304
   PubMed Web of Science ®Google Scholar
• WernickeJFWangFPritchettYLAn open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic painPain Med2007850351317716324
   PubMed Web of Science ®Google Scholar
• SkljarevskiVDesaiahDZhangQEvaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic painDiabetes Metab Res Rev20092562363119637208
   PubMed Web of Science ®Google Scholar
• RaskinJWangFPritchettYLGoldsteinDJDuloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety studyPain Med2006737338517014595
   PubMed Web of Science ®Google Scholar
• LunnMPHughesRAWiffenPJDuloxetine for treating painful neuropathy or chronic painCochrane Database Syst Rev20097CD00711519821395
   PubMed Web of Science ®Google Scholar
• GarciaMJMcNamaraPMKannelWBMorbidity and mortality in diabetics in the Framingham population: sixteen-year follow-up studyDiabetes1974231051114359625
   PubMed Web of Science ®Google Scholar
• American Diabetes Association, the National Heart, Lung and Blood Institutethe Juvenile Diabetes Foundation internationalthe national Institute of Diabetes and Digestive and Kidney Disease, and the American heart AssociationDiabetes mellitus: a major risk factor for cardiovascular diseaseCirculation19991001132113310477541
   PubMed Web of Science ®Google Scholar
• SowersJREpsteinMFrohlichEDDiabetes, hypertension, and cardiovascular disease: An updateHypertension2001371053105911304502
   PubMed Web of Science ®Google Scholar
• MaahsDMKinneyGLWadwaPHypertension prevalence, awareness, treatment and control in an adult type 1 diabetes population and a comparable general populationDiabetes Care20052830130615677783
   PubMed Web of Science ®Google Scholar
• MooreWVFredricksonDBrennerAPrevalence of hypertension in patient with type II diabetes in referral versus primary care clinicsJ Diabetes Complications1998123023069877462
   PubMed Web of Science ®Google Scholar
• ThaseMETranPVWiltseCCardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrineJ Clin Psychopharmacology200525132140
   PubMed Web of Science ®Google Scholar
• WernickeJFPrakashAKajdaszDKHoustonJSafety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditionsJ Diabetes Complications20092334935918768332
   PubMed Web of Science ®Google Scholar
• McIntyreRSSoczynskaJKKonarskiJZKennedySHThe effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanismsExpert Opin Drug Saf2006515716816370964
   PubMed Web of Science ®Google Scholar
• HardyTSachsonRShenSDoes treatment with duloxetine for neuropathic pain impact glycemic control?Diabetes Care200730212617192327
   PubMed Web of Science ®Google Scholar
• ZiereGDielemanJPvan der CammenTJSelective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fracturesJ Clin Psychopharmacol20082841141718626268
   PubMed Web of Science ®Google Scholar
• RaskinJSmithTRWongKDuloxetine versus routine care in the long-term management of diabetic peripheral neuropathic painJ Palliat Med20069294016430342
   PubMed Web of Science ®Google Scholar
• ChristensenJOSwendsenOLBone mineral in pre- and postmenopausal women with insulin dependent and non-insulin dependent diabetes mellitusOsteoporosis Int199910307311
   PubMed Web of Science ®Google Scholar
• StoneMLaughrenTJonesMLRisk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug AdministrationBMJ2009339b288019671933
   PubMed Web of Science ®Google Scholar
• O’ConnorABNoyesKHollowayRGA cost-utility comparison of four first-line medications in painful diabetic neuropathyPharmacoeconomics2008261045106419014205
   PubMed Web of Science ®Google Scholar
• WuEQBirnbaumHGMarevaMNCost-effectiveness of duloxetine versus routine treatment for US patients with diabetic peripheral neuropathic painJ Pain2006739940716750796
   PubMed Web of Science ®Google Scholar
• QuiliciSChancellorJLothgrenMMeta-analysis of duloxetine vs pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic painBMC Neurology20099619208243
   PubMed Web of Science ®Google Scholar
• ChenSYWuNBoulangerLThe relationship between average daily dose, medication adherence, and health-care costs among diabetic peripheral neuropathic pain patients initiated on duloxetine therapyPain Pract20101053053920412505
   PubMed Web of Science ®Google Scholar
• ZhaoYWuNChenSChanges in opioid use and healthcare costs among US patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapiesCurr Med Res Opin2010262147215620662557
   PubMed Web of Science ®Google Scholar
• SolomonDHRassenJAGlynnRFThe comparative safety of analgesics in older adults with arthritisArch Intern Med20101701968197621149752
   PubMed Web of Science ®Google Scholar
• SheltonRCThe nature of the discontinuation syndrome associated with antidepressant drugsJ Clin Psychiatry200667Suppl 43716683856
   PubMed Web of Science ®Google Scholar
• PerahiaDGKajdaszDKDesaiahDHaddadPMSymptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorderJ Affect Disord20058920721216266753
   PubMed Web of Science ®Google Scholar
• PerahiaDGQuailDDesaiahDSwitching to duloxetine from selective serotonin reuptake inhibitor antidepressants: a multicenter trial comparing 2 switching techniquesJ Clin Psychiatry2008699510518312043
   PubMed Web of Science ®Google Scholar